Investigating how the androgen receptor influences prostate cancer growth and treatment.
Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer
This study is looking at how a protein called the androgen receptor can change from helping normal prostate cells grow to fueling prostate cancer, and it aims to find ways to turn its cancer-fighting abilities back on to help stop the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11055791 on NIH RePORTER |
What this research studies
This research focuses on the role of the androgen receptor (AR) in prostate cancer, particularly how it can switch from promoting normal cell growth to driving cancer progression. The team aims to identify the factors that mediate this switch and explore whether the growth-suppressive functions of AR can be reactivated to inhibit cancer. By utilizing advanced biological models and novel systems to manipulate AR activity, the research seeks to enhance our understanding of AR's role in both normal prostate function and cancer development.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with advanced prostate cancer, particularly those whose disease has become resistant to current treatments.
Not a fit: Patients with early-stage prostate cancer or those without androgen receptor involvement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that reactivate the growth-suppressive functions of the androgen receptor, potentially improving outcomes for patients with advanced prostate cancer.
How similar studies have performed: Previous research has shown promising results in targeting the androgen receptor in prostate cancer, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Barbieri, Christopher E — Weill Medical Coll of Cornell Univ
- Study coordinator: Barbieri, Christopher E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.